Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Exact Sciences Corp.

https://www.exactsciences.com/

Latest From Exact Sciences Corp.

Guardant Health Launches New Firsts: Blood Test To Track Patient’s Response To Immunotherapy, Tissue-Based Test

Guardant’s launch of a new test to track patient’s response to immunotherapy or targeted drugs and new pan-cancer tissue test, brings it closer to “one-stop-shop” in cancer care continuum.

Cancer Launches

MCIT Rule Likely Too Broken For CMS To Implement In December, Analyst Predicts

John Leppard with Washington Analysis says the Medicare agency’s recent delay of the MCIT breakthrough devices rule until mid-December suggests the CMS will likely scrap it altogether and start from scratch.

Regulation Policy

CM Life Sciences II To Combine With Proteomics SomaLogic In Latest SPAC Deal

The SPAC deal between CM Life Sciences II and SomaLogic is valued at $1.25bn.

Financing Deals

PAVmed Plans Spin-Off And Marketing Push For Lucid Diagnostics

Lucid, which markets the EsoGuard test for Barrett’s esophagus, will become a separate public company, either through an IPO or a business combination with a health care SPAC.

M & A Cancer
See All

Company Information

  • Industry
  • Biotechnology
  • Laboratory Testing Services
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Other Names / Subsidiaries
    • Base Genomics
    • Genomic Health, Inc.
    • Paradigm Diagnostics, Inc.
    • Thrive Earlier Detection Corp.
    • Viomics, Inc.
UsernamePublicRestriction

Register